We Stand FIRM
FIRM Home
Blog Home
Recent Comments
RSS Feed
Twitter: WeStandFIRM

Contributors
Lin Zinser
Ari Armstrong
Diana Hsieh
Paul Hsieh
E-mail all the bloggers

Blogroll
AFCM
Lucidicus Project
Capitalism Magazine
Principles in Practice
Patient Power
Health Care BS
Wolf Files
Bradley Hennefent
Medpolitics
ReasonPharm
Concierge Medicine MD
Free Market Cure
KevinMD
John Goodman
Junkfood Science
Covert Rationing
NCPA Digest
Socialized Medicine
State House Call
Big Gov Health
WSJ Health Blog
Medical Progress Today
Seamus Muldoon
Free Colorado
Dr. Donald May
Heal Spiel
Health Policy Action Center

Articles/Essays:

"Health Care Is Not A Right"
"FAQ on Free Market Health Insurance"
More Articles/Editorials

FIRM Debates Universal Healthcare on Opposing Views


Archives
January 2007
February 2007
March 2007
April 2007
May 2007
June 2007
July 2007
August 2007
September 2007
October 2007
November 2007
December 2007
January 2008
February 2008
March 2008
April 2008
May 2008
June 2008
July 2008
August 2008
September 2008
October 2008
November 2008
December 2008
January 2009
February 2009
March 2009
April 2009
May 2009
June 2009
July 2009
August 2009
September 2009
October 2009
November 2009
December 2009
January 2010
February 2010
March 2010
 Tuesday, March 18, 2008
More Free Market Success
By Paul Hsieh, MD @ 12:01 AM PermaLink

The relatively free market continues to save money for consumers, this time in pharmaceutical expenses:
Wal-Mart Claims $4 Generics Have Saved Consumers $1 Billion

Wal-Mart's doing a bit of chest thumping this morning, claiming that its $4 generics program has saved consumers $1 billion — $1,032,573,012.61 as of March 10, to be precise.

The company says the $4 drugs now account for 40% of all prescriptions filled at its stores, adding that nearly 30% of the cheap prescriptions are purchased without insurance.

Wal-Mart breaks down the program by state, with the top savers being Texas ($132,628,224), Florida ($72,443,467) and North Carolina ($48,241,530).

The baseline figures the company used to calculate total savings are the average Wal-Mart price of each generic drug before the program launched. The calculations don't include the prices of branded (and much more expensive) drugs, a Wal-Mart spokeswoman told the Health Blog.

The ripple effects of the program may have driven additional consumer savings, the company pointed out. Competitors including Kroger and Target followed Wal-Mart with their own $4 generics programs.
If the partially free market we have in the US can benefit patients this much, think of how much a fully free market could benefit all of us. (Via David Catron.)

Labels:

E-mail Paul Hsieh, MD / PermaLink / Comments / Trackbacks / BlogThis